Merck & Co. - Forbes
Merck & Co. Forbes
Merck & Co Company News
Business Development Supports Merck & Co.’s (MRK) Next Growth Chapter - Yahoo Finance
Business Development Supports Merck & Co.’s (MRK) Next Growth Chapter Yahoo Finance
With oncology pipeline at ‘inflection point,’ Merck puts finish line in focus with new corporate campaign - Fierce Pharma
With oncology pipeline at ‘inflection point,’ Merck puts finish line in focus with new corporate campaign Fierce Pharma
27,441 Merck & Co., Inc. $MRK Shares Purchased by Vestor Capital LLC - MarketBeat
27,441 Merck & Co., Inc. $MRK Shares Purchased by Vestor Capital LLC MarketBeat
The new R&D and manufacturing facilities powering our US growth - Merck | Home
The new R&D and manufacturing facilities powering our US growth Merck | Home
884,504 Merck & Co., Inc. $MRK Shares Sold by Beutel Goodman & Co Ltd. - MarketBeat
884,504 Merck & Co., Inc. $MRK Shares Sold by Beutel Goodman & Co Ltd. MarketBeat
Merck & Co. stock slips as HIV pipeline stays in focus - ad-hoc-news.de
Merck & Co. stock slips as HIV pipeline stays in focus ad-hoc-news.de
Girding against Keytruda cliff, Merck splits oncology into standalone business unit - Fierce Pharma
Girding against Keytruda cliff, Merck splits oncology into standalone business unit Fierce Pharma
Merck & Co., Inc. $MRK Stock Bought by Red Cedar Investment Management LLC - MarketBeat
Merck & Co., Inc. $MRK Stock Bought by Red Cedar Investment Management LLC MarketBeat
Our Q2 2026 financial results - Merck | Home
Our Q2 2026 financial results Merck | Home
Merck & Co., Inc. $MRK Stock Purchased by Fulcrum Asset Management LLP - MarketBeat
Merck & Co., Inc. $MRK Stock Purchased by Fulcrum Asset Management LLP MarketBeat
37,653 Merck & Co., Inc. $MRK Shares Sold by AEGON ASSET MANAGEMENT UK Plc - MarketBeat
37,653 Merck & Co., Inc. $MRK Shares Sold by AEGON ASSET MANAGEMENT UK Plc MarketBeat
Candriam S.C.A. Acquires 48,149 Shares of Merck & Co., Inc. $MRK - MarketBeat
Candriam S.C.A. Acquires 48,149 Shares of Merck & Co., Inc. $MRK MarketBeat
7,868 Merck & Co., Inc. $MRK Shares Sold by Carnegie Lake Advisors LLC - MarketBeat
7,868 Merck & Co., Inc. $MRK Shares Sold by Carnegie Lake Advisors LLC MarketBeat
Ethic Inc. Acquires 20,816 Shares of Merck & Co., Inc. $MRK - MarketBeat
Ethic Inc. Acquires 20,816 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kornitzer Capital Management Inc. KS - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kornitzer Capital Management Inc. KS MarketBeat
Merck & Co., Inc. $MRK Stock Sold by Alps Advisors Inc. - MarketBeat
Merck & Co., Inc. $MRK Stock Sold by Alps Advisors Inc. MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Alta Advisers Ltd - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Alta Advisers Ltd MarketBeat
Merck & Co., Inc. $MRK Stock Acquired by Compass Financial Management LLC - MarketBeat
Merck & Co., Inc. $MRK Stock Acquired by Compass Financial Management LLC MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Commonwealth Equity Services LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Commonwealth Equity Services LLC MarketBeat
Merck & Co. stock gains as HIV pipeline takes center stage - ad-hoc-news.de
Merck & Co. stock gains as HIV pipeline takes center stage ad-hoc-news.de
Merck & Co., Inc. $MRK Shares Sold by Boston Trust Walden Corp - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Boston Trust Walden Corp MarketBeat
Associated Banc Corp Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Associated Banc Corp Makes New Investment in Merck & Co., Inc. $MRK MarketBeat
15,279 Merck & Co., Inc. $MRK Shares Bought by Provenance Wealth Advisors LLC - MarketBeat
15,279 Merck & Co., Inc. $MRK Shares Bought by Provenance Wealth Advisors LLC MarketBeat
First Nebraska Trust Co Buys 102,205 Shares of Merck & Co., Inc. $MRK - MarketBeat
First Nebraska Trust Co Buys 102,205 Shares of Merck & Co., Inc. $MRK MarketBeat
8,663 Merck & Co., Inc. $MRK Shares Sold by Factory Mutual Insurance Co. - MarketBeat
8,663 Merck & Co., Inc. $MRK Shares Sold by Factory Mutual Insurance Co. MarketBeat
Our Q4 and full-year 2025 financial results - Merck
Our Q4 and full-year 2025 financial results Merck
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) - Merck | Home
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) Merck | Home
Merck & Co. stock gains two pipeline catalysts ahead of data week - ad-hoc-news.de
Merck & Co. stock gains two pipeline catalysts ahead of data week ad-hoc-news.de
Merck & Co. stock: HIV Glasgow adds pipeline milestones - ad-hoc-news.de
Merck & Co. stock: HIV Glasgow adds pipeline milestones ad-hoc-news.de
Merck | Home - Merck | Home
Merck | Home Merck | Home